Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Scientist, Bioassay (Analytical Development)

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Dec 7, 2021

Job Details

Why Join Intellia? 

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. 

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done. 

We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.   

How you will Achieve More with Intellia:

We are excited to welcome this new member to our growing team and company. This is both a strategic and lab-based role. If you are a strong problem-solver, have strong assay development experience, and enjoy cross-functional partnerships, this is the role for you! As the Senior Scientist, Bioassay, you will work on various projects including:

  • Developing, optimizing, and qualifying molecular-based, immunoassay, and characterization assays with established assay acceptance criteria for gene & cell therapy product characterization, lot release, and stability testing

  • Supporting as SME in tech transfer of analytical methods, protocols/procedures, and know-how from internal labs to external labs 

  • Performing routine and non-routine analytical testing, coordinating with internal/external PD or cGMP manufacturing on sample testing, compiling and presenting data to support process development and developmental stability studies

  • Evaluating novel assay technologies and methodologies that could improve existing analytical methods

  • Authoring and review SOPs, development reports, and assist in the preparation of CMC regulatory submissions

  • Assisting in maintaining/qualification of critical reagent supply for assigned methods

  • Working collaboratively with Analytical Development, Process Development, and Quality teams to gather and analyze data to achieve method readiness

  • Working closely with, and support quality control on investigations, OOS, OOTs and release assay troubleshooting

  • Maintaining well-documented records of analytical data, laboratory notebooks, execution of assays & stability data

About You:

Our ideal candidate has a degree in Biochemistry, Cell & Molecular biology, Genetics, or related disciplines with experience working within Analytical Development. This candidate will have the scientific knowledge to mentor junior scientists to develop methods required for late-stage products. If you describe yourself as a team player who loves method development, this role is for you!  Other desired skills include:

  • Experience in biotech or pharma industry with a primary focus on biologics and/or gene and cell therapy

  • Managerial experience desirable

  • Critical thinking, troubleshooting, and attention to detail are a must. You will be required to plan & execute experiments as well as analyze data generated at other sites for method improvements

  • AAV and/or Cell Therapy experience is highly desired

  • In-depth knowledge of molecular assays such as qPCR, ddPCR, and/or ELISA and enzymatic assays experience is required

  • Knowledge of FDA, cGMP, and ICH regulatory requirements in the context of bioassay/potency assay development and qualification is desired

  • Experience and knowledge of QC and GMP regulations is essential

  • Must be able to generate SOPs and technical reports with an appropriate level of detail, as well as perform bioassay trending

  • Experience working with CROs

  • A good understanding of statistical methods/tools for data analysis is a strong plus

  • Team player with good interpersonal and organizational skills

Meet your future team:

Analytical Development is a collaborative group supporting Process Development, Manufacturing, and Quality. You will report to the Principal Scientist, Analytical Development. This role will be responsible for assays supporting all modalities within analytical development and you will be responsible for building out the Testing Group in support of our overall efforts.

#LI-LN1

Covid-19 Vaccination Policy: Effective Monday, January 3, 2022, all Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert